Noblett Karen 4
4 · Axonics, Inc. · Filed Dec 28, 2023
Insider Transaction Report
Form 4
Axonics, Inc.AXNX
Noblett Karen
Chief Medical Officer
Transactions
- Sale
Common Stock
2023-12-28$63.28/sh−7,051$446,177→ 34,215 total - Sale
Common Stock
2023-12-26$63.00/sh−949$59,787→ 41,266 total
Footnotes (2)
- [F1]This sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan entered into on September 15, 2023.
- [F2]This transaction was executed in multiple trades at prices ranging from $63.00 to $63.8425. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.